Evaluation of the Immunogenicity of a <i>Mycobacterium intracellulare</i> Clinical Isolate
These findings suggest that potential applications in the immunoprevention and treatment of tuberculosis, and the Mit strain CHPC 1.5701 is identified as a promising candidate for tuberculosis vaccine development.
Authors
- Hongyang Duan (ORCID: https://orcid.org/0000-0002-1840-4682)
- Xiuqin Zhao
- Da Xu (ORCID: https://orcid.org/0000-0002-5819-9142)
- Ruihuan Wang (ORCID: https://orcid.org/0000-0003-0235-952X)
- Haican Liu (ORCID: https://orcid.org/0000-0002-9420-1211)
- Guilian Li (ORCID: https://orcid.org/0000-0002-7656-2304)
- Kanglin Wan
- Yujie Gu
- Machao Li
Institutions
- Chinese Center For Disease Control and Prevention (CN)
- National Institute for Communicable Disease Control and Prevention (CN)
Publication Details
- Journal
- China CDC Weekly
- Published
- 2025-01-01
- DOI
- https://doi.org/10.46234/ccdcw2025.142
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00